Skip to main content
. 2020 Jun 3;28(10):537–545. doi: 10.1007/s12471-020-01433-x

Table 2.

Subcohort of non-ST-elevation myocardial infarction patients alive at 30 days: medication use at 30 days

Total complete optimal medical treatment use  8,144(47%)
Aspirin species 15,769(91%)
P2Y12 inhibitor 13,170(76%)
Statin 14,729(85%)
Beta-blocker 12,823(74%)
ACE inhibitor/AT2 receptor blocker 12,996(75%)

ACE angiotensin converting enzyme, AT2 angiotensin II